Danaher Co. (NYSE:DHR) Shares Sold by King Luther Capital Management Corp

King Luther Capital Management Corp lowered its position in Danaher Co. (NYSE:DHR) by 0.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,681,550 shares of the conglomerate’s stock after selling 2,354 shares during the quarter. Danaher comprises about 2.0% of King Luther Capital Management Corp’s holdings, making the stock its 9th biggest holding. King Luther Capital Management Corp owned approximately 0.23% of Danaher worth $467,505,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in DHR. CarsonAllaria Wealth Management Ltd. purchased a new position in shares of Danaher during the second quarter worth $25,000. nVerses Capital LLC acquired a new position in Danaher in the second quarter valued at approximately $25,000. MidAtlantic Capital Management Inc. purchased a new position in Danaher in the third quarter valued at approximately $40,000. MFA Wealth Advisors LLC purchased a new stake in shares of Danaher during the 2nd quarter worth approximately $51,000. Finally, Financial Connections Group Inc. acquired a new stake in Danaher during the 2nd quarter worth $51,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Trading Up 1.0 %

NYSE DHR opened at $233.10 on Thursday. Danaher Co. has a 52 week low of $213.61 and a 52 week high of $281.70. The stock has a market cap of $168.36 billion, a P/E ratio of 44.48, a PEG ratio of 4.24 and a beta of 0.85. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The company’s fifty day simple moving average is $259.67 and its 200-day simple moving average is $260.13.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business had revenue of $5.80 billion for the quarter, compared to analysts’ expectations of $5.59 billion. During the same quarter in the previous year, the firm posted $2.02 earnings per share. The company’s revenue was up 3.1% compared to the same quarter last year. Equities research analysts predict that Danaher Co. will post 7.51 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were issued a $0.27 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 annualized dividend and a yield of 0.46%. Danaher’s dividend payout ratio is presently 20.61%.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on DHR. Stephens reissued an “overweight” rating and issued a $315.00 target price on shares of Danaher in a research report on Wednesday, October 23rd. Wells Fargo & Company initiated coverage on Danaher in a research note on Tuesday, August 27th. They set an “equal weight” rating and a $280.00 target price for the company. Bank of America increased their price objective on Danaher from $270.00 to $275.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 24th. Evercore ISI boosted their target price on shares of Danaher from $275.00 to $278.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 1st. Finally, Royal Bank of Canada cut their price target on shares of Danaher from $333.00 to $311.00 and set an “outperform” rating for the company in a report on Wednesday, October 23rd. Six research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $287.16.

Insider Buying and Selling at Danaher

In other news, SVP Georgeann Couchara sold 952 shares of the company’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $268.37, for a total value of $255,488.24. Following the sale, the senior vice president now owns 4,212 shares in the company, valued at approximately $1,130,374.44. This represents a 18.44 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 10.90% of the stock is currently owned by insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.